Leerink Partners Downgrades InflaRx to Market Perform, Lowers Price Target to $2
Benzinga Newsdesk 11 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Leerink Partners analyst Joseph Schwartz downgrades InflaRx (NASDAQ:IFRX) from Outperform to Market Perform and lowers the price target from $5 to $2.
Leerink Partners analyst Joseph Schwartz downgrades InflaRx (NASDAQ:IFRX) from Outperform to Market Perform and lowers the price target from $5 to $2.